← Back to Clinical Trials
Recruiting NCT06491056
Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)
Trial Parameters
Condition Prostate Cancer
Sponsor Singapore General Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 500
Sex MALE
Min Age 40 Years
Max Age 85 Years
Start Date 2023-05-06
Completion 2028-05-06
Interventions
Focal Therapy for Prostate Cancer
Brief Summary
This is a multicenter observational study of patients undergoing focal therapy for prostate cancer in Asia
Eligibility Criteria
Inclusion Criteria: * Prostate Adenocarcinoma * Maximum Gleason score 4+4 * Maximum cancer volume 1.5 ml (up to 2 lesions) or 3 ml (single lesion) * Maximum Prostate Specific Antigen (PSA) level 15 ng/dl * Maximum clinical stage T2c * American Society of Anesthesiologist Criteria 2 or less Exclusion Criteria: * Extra-prostatic Extension on multi parametric magnetic resonance imaging (mpMRI); capsular contact is permitted